# FDA Inspection 1330676 - Alexion Pharmaceuticals, Inc. - July 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/d21c7be0-6f07-4567-9c27-621822a1d9a9
Source feed: FDA_Inspections

> FDA Inspection 1330676 for Alexion Pharmaceuticals, Inc. on July 28, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1330676
- Company Name: Alexion Pharmaceuticals, Inc.
- Inspection Date: 2026-07-28
- Product Type: Human Drugs
- Office Name: New England District Office

## Related Documents

- [FDA Inspection 1326206 - 2026-07-01](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/cc22fe01-26f5-4c2e-b38f-138916459342)
- [FDA Inspection 1262947 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5fb2d391-dc92-43ec-a7a3-bbb58a161055)
- [FDA Inspection 1262947 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/deefafb0-cf26-41b8-a8f2-e29bc44947cf)
- [FDA Inspection 1254018 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5b301914-bf94-449d-9b3e-8f8c86990b4e)
- [FDA Inspection 1254018 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/27326ddb-c4b0-4290-b6d1-c15f6fbaccc0)

Company: https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144